[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356405-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356405-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","homotypic-membrane-powered-electrochemical-microfluidic-analysis-of-extracellular-vesicles-for-precise-cancer-diagnosis","Homotypic membrane-powered electrochemical microfluidic analysis of extracellular vesicles for precise cancer diagnosis","","Homotypic membrane-powered biomimetic interfaces are developed for subtype-specific analysis of breast cancer extracellular vesicles (EVs) to support precise diagnosis. A breast cancer cell membrane coats a gold substrate to selectively bind EVs showing similar subtype features, followed by silver nanoparticle-tethered antibodies as electroactive immunoprobes to generate quantifiable electrochemical signals. The interface demonstrates high selectivity and sensitivity, and an electrochemical microfluidic device is validated for identifying patient subtype features, enabling simple and efficient personalized cancer management.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/homotypic-membrane-powered-electrochemical-microfluidic-analysis-of-extracellular-vesicles-for-precise-cancer-diagnosis/356405/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/homotypic-membrane-powered-electrochemical-microfluidic-analysis-of-extracellular-vesicles-for-precise-cancer-diagnosis/356405.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does the breast cancer cell membrane interface work for EV binding?","Question",{"text":63,"@type":64},"The breast cancer cell membrane is used to coat a gold substrate, creating a biomimetic interface that selectively binds breast cancer EVs with similar subtype features through homotypic interactions.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role do silver nanoparticles-tethered antibodies play in the assay?",{"text":68,"@type":64},"Silver nanoparticles-tethered antibodies label the bound EVs and act as electroactive immunoprobes, producing distinct electrochemical signals for quantitative analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"How is the electrochemical microfluidic device validated for cancer diagnosis?",{"text":72,"@type":64},"The study reports developing an electrochemical microfluidic device based on the biomimetic interface and validating its effectiveness in identifying subtype features of breast cancer patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356405,1790200038,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":26,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article [https://doi.org/10.1038/s41467-026-68770-0](https://doi.org/10.1038/s41467-026-68770-0)  \nHomotypic membrane-powered electrochemical microﬂuidic analysis of extracellular vesicles for precise cancer diagnosis  \nReceived: 3 March 2025  \n\n| Accepted: 16 January 2026 |\n| --- |\n| |\n| Check for updates |\n\nZihan Zou1,5, Xi Jin2,5, Xiaomeng Yu3, Lijuan Li1, Yi Pan1, Guozhang Zhou1, Zhaoyin Wang4 , Ya Cao1  & Jing Zhao 1   \nThe cancer cell membrane, rich in tumor-associated antigens, effectively replicates the characteristics of cancer cells by presenting speciﬁc protein proﬁles. Leveraging the inherent binding capability of the cancer cell membrane, here we show a homotypic membrane-powered biomimetic interface for subtype-speciﬁc analysis of breast cancer extracellular vesicles (EVs). Speciﬁcally, the breast cancer cell membrane is employed to coat a gold substrate, thereby forming the biomimetic interface capable of selectively binding breast cancer EVs with similar subtype features. Subsequently, silver nanoparticles-tethered antibodies are adopted as electroactive immunoprobes to label these EVs, generating distinct electrochemical signals for quantitative analysis. Research ﬁndings demonstrate high selectivity and sensitivity of the interface for analyzing target EVs. Based on this, an electrochemical microﬂuidic device is developed and validated for its effectiveness in identifying subtype features of breast cancer patients. Therefore, our work provides a simple yet efﬁcient platform for precise cancer diagnosis and personalized treatment.  \nCell membranes, serving as vital biological barriers that regulate the movement of bioactive molecules in and out of the cell through selective permeability, play an essential role in maintaining cellular homeostasis and facilitating cellular communication1. The bilayer structure of cell membranes, composed of lipids, proteins, and carbohydrates, is indispensable for cell recognition, molecular adhesion, and signal transduction, which are involved in various biological processes within an organism. Notably, when employed in the construction of biometric interfaces, cell membranes are capable of retaining  \nthe unique characteristics of their parent cells and performing cellspeciﬁc functions2. For example, red blood cell membranes, the main source of membrane materials in the bloodstream, enable prolonged circulation without provoking an immune response3–5; platelet membranes, owing to their role in hemostasis and inﬂammation, facilitate subcellular targeting for drug delivery while remaining nonimmunogenic6–8; cancer cell membranes, enriched with tumorassociated biocomponents (such as antigens and lipids), effectively mimic the properties of cancer cells, promoting selective binding to  \n1Center for Molecular Recognition and Biosensing, Shanghai Engineering Research Center of Organ Repair, Joint International Research Laboratory of Biomaterials and Biotechnology in Organ Repair (Ministry of Education), School of Life Sciences, Shanghai University, Shanghai, China. 2Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. 3State Key Laboratory of Analytical Chemistry for Life Science, School of Life Sciences, Nanjing University, Nanjing, China. 4Jiangsu Collaborative Innovation Center of Biomedical Functional Materials and Jiangsu Key Laboratory of Biofunctional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, China. 5These authors contributed equally: Zihan Zou, Xi Jin. e-mail: [zywang@njnu.edu.cn](zywang@njnu.edu.cn); [conezimint@shu.edu.cn](conezimint@shu.edu.cn); [jingzhao@t.shu.edu.cn](jingzhao@t.shu.edu.cn)  \nhomologous tumors and aiding in the development of tumor vaccines9–12. Moreover, studies have shown that camouﬂaging solid substrates with cell membranes can effectively preserve their functional biomolecules and achieve speciﬁc recognition and detection of target mole","cbCaipunPiOyAek8","https://ap.wps.com/l/cbCaipunPiOyAek8","pdf",3782692,"English","# Homotypic membrane-powered biomimetic interface for EV analysis\n## Cell membrane–based biomimetic coating and selective EV binding\n## Electroactive immunoprobes and electrochemical signal generation\n## Breast cancer subtype features and EV molecular profiling\n## Electrochemical microfluidic device development and validation","[{\"question\":\"How does the breast cancer cell membrane interface work for EV binding?\",\"answer\":\"The breast cancer cell membrane is used to coat a gold substrate, creating a biomimetic interface that selectively binds breast cancer EVs with similar subtype features through homotypic interactions.\"},{\"question\":\"What role do silver nanoparticles-tethered antibodies play in the assay?\",\"answer\":\"Silver nanoparticles-tethered antibodies label the bound EVs and act as electroactive immunoprobes, producing distinct electrochemical signals for quantitative analysis.\"},{\"question\":\"How is the electrochemical microfluidic device validated for cancer diagnosis?\",\"answer\":\"The study reports developing an electrochemical microfluidic device based on the biomimetic interface and validating its effectiveness in identifying subtype features of breast cancer patients.\"}]","Homotypic membrane-powered electrochemical microfluidic analysis of extracellular vesicles for precise cancer diagnosis | PDF",1790125209,35,[147,151],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/89ce014159f6c79ab431f99378f0bf20.webp",983,1306,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/2c8b88313413f99ced2002d3f54ebb80.webp",982,1304]